Medical Marijuana Inc CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article on Medical Marijuana Inc.’s ( OTC PINK : MJNA ) new HempMeds®

Medical Marijuana Inc.’s (MJNA) Opens Office in Mexico with Leading Advocate

HempMeds Opens Office in Mexico with Leading Advocate

Medical Marijuana Inc CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article on Medical Marijuana Inc.’s ( OTC PINK : MJNA ) new HempMeds®

FOREX INVESTORS  PRESS RELEASE  Medical Marijuana Inc CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article on Medical Marijuana Inc.’s ( OTC PINK : MJNA ) new HempMeds® office in Mexico and why it’s a significant development for the company.
Mexico’s Progressive Stance

Mexico has been historically opposed to marijuana legalization thanks to the United States’ War on Drugs since the 1970s. Since the 1990s, Mexican drug cartels have grown in power following the demise of the Colombian Cali and Medellin cartels. Analysts estimate that wholesale earnings from illicit drug sales range from $13.6 billion to $49.4 billion each year, which is on par with multinational tobacco companies that earn about $30 billion per year.



Medical Marijuana Inc

 

After many US states began taking a more progressive approach by legalizing marijuana, Mexico’s Senate passed a bill legalizing medical marijuana in December 2016. The country’s lower house in parliament followed suit by passing the bill in late-April with an overwhelming 374-7 vote. President Enrique Pena Nieto officially signed the bill into law last month, which makes medical marijuana available and legal throughout the country.

The Health Ministry will now be tasked with creating regulations around the use of medical marijuana, including the production of cannabinoid-based pharmaceuticals. In the meantime, consumers will be permitted to legally purchase cannabinoid products that contain 1% or less tetrahydrocannabinol (THC), while companies will be permitted to cultivate cannabis for medical and scientific purposes without being punished by law.

Establishing a Footprint

Medical Marijuana Inc. has been a pioneer in Mexico’s cannabinoid industry. Last year, the company secured the first import permit for RSHO-X™ — a non-psychoactive cannabidiol (CBD) hemp oil for patients suffering from severe seizures — from COFEPRIS — the country’s health authority. Many other patients have since secured import rights for the CBD oil that has shown tremendous promise in helping patients overcome severe seizures.

Earlier this year, the company began groundbreaking new studies of its RSHO-X™ in Mexico under the direction of pediatric neurologist Dr. Saul Garza Morales. The results of these studies showed a 50% or greater reduction in seizures in 33 of 39 patients, while over half of patients achieved an overall 75% reduction in seizures. But, perhaps the most striking result was the 100% seizure relief experienced by about 17% of patients in the study.

HempMeds® is expanding its presence with the opening of its first office in Monterrey, Nuevo Leon, Mexico, as demand continues to grow for RSHO-X™. The new office will be managed by medical cannabis activist and Por Grace Foundation founder Raul Elizalde and act as a hub for the sales, marketing, and distribution of RSHO-X™ to patients in Mexico. The company also aims to further its efforts to push for cannabis reform in the country. Major news outlets attended the inauguration including Forbes Mexico, HuffPost, and El Financiero among others.

Mr. Elizalde’s daughter, Grace, was the first Mexican patient to gain legal access to CBD oil, for the control of her seizures. He is recognized throughout the country for his determined efforts to expand access for more patients, and even joined President Nieto on stage in April as he announced the country’s intentions to legalize medical marijuana. His tireless dedication to the cause, and the resulting renown, should benefit the company as it grows its footprint throughout Mexico.

For more information, visit the company’s website or CannabisFN’s company profile.Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )



BUZ INVESTORS Marijuana Penny Stock Early marijuana investors got lucky with marijuana penny stocks. But sadly, for those who missed the early-bird discount,

Is MJNA Stock the Top Marijuana Penny Stock?

|Chart | Calendar   | TRADE NOW | CANNABIS

Top Marijuana Penny Stock with Great Upside Potential

 

BUZ INVESTORS Marijuana Penny Stock  Early marijuana investors got lucky with marijuana penny stocks. But sadly, for those who missed the early-bird discount, these marijuana penny stocks have now graduated into the higher ranks. However, I’ve hunted down one top marijuana penny stock in 2017 that’s still selling for pennies on the dollar. So, my friends, perk up for Medical Marijuana Inc (OTCMKTS:(MJNA), because MJNA stock could turn out to be the next multibagger.

But first, a heads-up for those who are new to marijuana investing. Thanks to the medical community, this “sinful” drug has finally managed to break the shackles of social stigma. Marijuana has made its way to the mainstream, where doctors have discovered great benefits in its medicinal properties, particularly to cancer, epilepsy, and AIDS patients.

Marijuana Penny Stock

The cherry on top is the official legalization of medical marijuana in North America. Take note that 29 U.S. states so far have given its medical use a green light, with more states being added to that list. Also, right next door, Canada has already legalized medical marijuana and is going one step beyond with an official country-wide legalization of its recreational use by 2018

Why MJNA Stock Is a Top Marijuana Penny Stock

Medical Marijuana Inc sells itself as the “company of firsts.” Allow me to explain.

The company lays claim to many “firsts” in the marijuana industry. It was not only the first publicly traded marijuana company in the U.S., but it also proclaims to be the first in the country to bring cannabis-based foods and supplements to the mainstream. (Source: “We Are a Company of Firsts,” Medical Marijuana Inc, last accessed May 26, 2017.)

But look beyond its growing success on its home ground, and you’ll find the company making international headlines.

Medical Marijuana Inc has now also become the first public company to introduce medical marijuana products to Mexico, Puerto Rico, Brazil, and Paraguay.

At roughly $0.11, the stock is extremely cheap, making it an attractive growth play. I won’t shy away from calling it one of the top marijuana penny stocks in 2017.

MJNA stock chart

Chart courtesy of StockCharts.com

Bottom Line on Medical Marijuana MJNA Stock

Marijuana stocks are on a tear for a good reason. The marijuana industry outlook seems very promising. But not all marijuana stocks are worth betting on. Marijuana penny stocks are particularly fraught with risk.

Business Description

Industry: Drug Manufacturers » Drug Manufacturers – Specialty & Generic    NAICS: 325412    SIC: 2834
Compare: OTCPK:(OGRMF), NAS:(NEOS), NAS:(STDY), NAS:(ZYNE), NAS:(CPRX), NAS:(DRRX), OTCPK:(ELTP), OTCPK:(CURR), NAS:(COLL), OTCPK:(CMMDF), NAS:(SNDX), OTCPK:(ZOMHF), NAS:(SMMT), NAS:(MSLI), NAS:(TTPH), NAS:(TOCA), NAS:(RIGL), OTCPK:(CPHRF), OTCPK:(EMMBF), NAS:(ADMP) » details
Headquarter Location: USA

Medical Marijuana Inc is engaged in the development, sale and distribution of cannabinoid based health and wellness products and the development of medical grade compounds. Its portfolio of products and services solely focused on legal hemp industry.

Medical Marijuana Inc was originally incorporated in Oregon in 2005 as Berkshire Collection, Inc. The Company changed its name on two separate occasions prior to changing its name to Medical Marijuana, Inc. The Company through its subsidiaries is engaged in the development, sale and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol and other products containing CBD-rich hemp oil. Its products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements, prescription-based hemp oil for sale in countries that have legalized our hemp oil for the treatment of various illnesses. The Company’s services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. Its services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal cannabinoid industry.

 

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )

Medical Marijuana, Inc.'s CBD Oil RSHO-X™ Garners National News Headlines Across Mexico For Significantly Reducing Seizures Of Epileptic Children Articles Focus On RSHO-X™ Study Conducted on Severe Epileptic Children By Mexican Neurologist Who Reported Elimination in Seizures in 17% of Cases and Reduction of Motor Seizures in 84% of Cases

$MJNA CBD Oil Attracts National Headlines Across Mexico

Medical Marijuana, Inc.’s CBD Oil RSHO-X™ Garners National News Headlines Across Mexico For Significantly Reducing Seizures Of Epileptic Children

Articles Focus On RSHO-X™ Study Conducted on Severe Epileptic Children By Mexican Neurologist Who Reported Elimination in Seizures in 17% of Cases and Reduction of Motor Seizures in 84% of Cases

Medical Marijuana, Inc.'s CBD Oil RSHO-X™ Garners National News Headlines Across Mexico For Significantly Reducing Seizures Of Epileptic Children Articles Focus On RSHO-X™ Study Conducted on Severe Epileptic Children By Mexican Neurologist Who Reported Elimination in Seizures in 17% of Cases and Reduction of Motor Seizures in 84% of Cases

Buz Investors CBD Oil Attracts National Headlines Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Mexico garnered national news headlines across Mexico for the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of its RSHO-X™ product in treating children with severe epilepsy. HempMeds® Mexico was the first company to receive government import permits for its cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™) via the Mexican Health Department COFEPRIS.

An article from Mexico newspaper Reforma, “Ayuda cannabidiol a 84% de pacientes,” or “Cannabidiol helps 84% of patients,” explained how 84 percent of children with epilepsy treated with RSHO-X™ halved the number of seizures they suffer from, according to this first clinical study on the use of cannabis in patients with Lennox-Gastaut syndrome in Mexico.

 



“We are proud that our cannabidiol (CBD) hemp oil product, without THC, has enabled 17% of patients in the study to experience 100 percent relief from their seizures, the best results of any product/medication in the world regarding the reduction of seizures in Lennox-Gastaut patients,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It is exciting to see such widespread news coverage of these study results by the Mexico media, as studies that prove the therapeutic benefits of CBD like Dr. Garza’s study will continue to help fuel less restrictive medical cannabis programs not only in Mexico, but across the globe. In addition, as news spreads of this revolutionary treatment for diseases such as epilepsy, more patients and families that suffer from debilitating medical conditions will receive help with medical marijuana.”

The study included 39 patients with Lennox-Gastaut syndrome, a severe form of pediatric epilepsy that typically develops before the age of 4. Of those 39 patients, who took up to 5-7mg CBD/kg progressive doses of RSHO-X™ 5000MG, 84% experienced a 50% or greater reduction in motor seizures; 53% reported better than a 75% reduction in seizures; and seven reported a complete elimination of all seizures (17%) over a four-month period, with zero reported side effects.

Results of this study are set to be published in the near future. To view the study, click here.

Other major national Mexico outlets that have reported the results of Dr. Garza’s epilepsy study with RSHO-X™ include:

Contenido

Economiahoy.mx

El Diario.mx

El Imparcial

El Mural

El Universal

Frontera.info

La Cronica

La Jornada

Radio Centro

Yahoo Mexico

Zocalo

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here.



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Buz Investors Approved in Brazil for Autism CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis

$MJNA RSHO Approved in Brazil for Autism

Medical Marijuana Inc.’s RSHO Approved in Brazil for Autism — CFN Media

Buz Investors Approved in Brazil for Autism CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis

Buz Investors Approved in Brazil for Autism CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Medical Marijuana Inc.’s (OTC PINK: MJNA) Real Scientific Hemp Oil (RSHO™).

Medical Marijuana Inc.’s RSHO™ is a natural, full-spectrum cannabidiol (CBD) oil extracted from hemp plants grown in Northern Europe. The non-GMO hemp is cultivated without the use of herbicides, pesticides, or chemical fertilizers and the resulting CBD oil passes all federal requirements for open importation into the United States, as well as strict European Union regulations governing exports.



OTHER STORIES BUZ TRADERS FOLLOW

Approved in Brazil for Autism

 

Medical Marijuana Inc. recently announced that its HempMeds Brasil subsidiary secured approval for a prescription for RSHO to treat a patient with autism spectrum disorder. The move follows earlier approvals for the treatment of multiple sclerosis and Alzheimer’s disease, but marks the first time that Brazil’s National Health Surveillance Agency (ANVISA) has granted a prescription of the company’s RSHO™ for autism.

Mexican neurosurgeon Dr. Saul Garza also indicated that he is enrolling patients for a study on the effects of CBD on autism. Earlier, Dr. Garza concluded a study on Lennox-Gastaut epilepsy in Mexico with favorable results for the botanical CBD version that is allowed into Mexico (RSHO-X). These results will be published in the near future and presented at the International Epilepsy Congress in Barcelona, Spain on September 2-6, 2017.

Please follow the link to read the full article: http://www.cannabisfn.com/medical-marijuana-inc-s-rsho-approved-brazil-autism/

Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone:https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:http://www.cannabisfn.com

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit http://www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )